COO

Cooper Companies

Stock NYSE – Stock Market Prices, News & Analysis

Cooper Companies specializes in health care products, including soft contact lenses and women's health solutions.

$ 70.17
1.76 %

Cooper Companies

$ 70.17
1.76 %
COO

Cooper Companies specializes in health care products, including soft contact lenses and women's health solutions.

Price history of Cooper Companies
Price history of Cooper Companies

Performance & Momentum

6 Months 0.41 %
1 Year 10.23 %
3 Years 23.80 %
5 Years 27.26 %

Strategic Analysis

Cooper Companies • 2026

Cooper Companies positions itself in the American market for specialized medical devices in eye health and women's healthcare, with strong expertise in soft contact lenses. Its business model is based on technological innovation and the loyalty of a demanding professional clientele in these niche segments.

Strengths
  • Recognized leader in the field of eye health products with an innovative range of contact lenses
  • Clear positioning in high value-added segments that are less sensitive to economic cycles
  • Ability to develop integrated solutions combining medical technology and personalized care
Weaknesses
  • Disappointing stock performance in the medium and long term, reflecting difficulties in maintaining growth momentum
  • Dependence on the American markets with limited exposure internationally
Momentum

The displayed momentum remains moderately positive, indicating an attempt to rebound after a period of declining stock performance. This dynamic calls for caution but highlights a possible stabilization, justifying careful monitoring of upcoming results and innovations.

Analysis performed 1 month ago

Similar stocks to Cooper Companies

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone